While no study was conducted on the therapeutic effects of IDO2 inhibitor, recent studies highlight the protective effects of IDO1 inhibitors such as DWG-1036 [44], PF0684003 [45], and RY103 [46] on AD pathology from preclinical models in both cell lines and mouse models. This evidence concerns the gene IDO2 and Alzheimer disease.